SHSE:603439 (China)
Â
Class A
Â¥
12.82
(+0.55%)
Jun 21
New Key Statistics Module, Z-Score and F-Score
SHSE:603439 Key Ratios
Market Cap ¥ M | 5,254.43 |
Enterprise Value ¥ M | 5,270.41 |
P/E(ttm) | 17.81 |
PE Ratio without NRI | 17.66 |
Forward PE Ratio | -- |
Price/Book | 3.41 |
Price/Sales | 3.07 |
Price/Free Cash Flow | 25.69 |
Price/Owner Earnings | 21.73 |
Payout Ratio % | 0.14 |
Revenue (TTM) ¥ M | 1,708.00 |
EPS (TTM) ¥ | 0.72 |
Beneish M-Score | -2.09 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 17.90 |
y-y EBITDA Growth Rate % | 25.10 |
EV-to-EBIT | 15.24 |
EV-to-EBITDA | 15.24 |
PEG | 0.99 |
Shares Outstanding M | 409.86 |
Net Margin (%) | 17.20 |
Operating Margin % | 17.28 |
Pre-tax Margin (%) | 19.80 |
Quick Ratio | 1.67 |
Current Ratio | 1.96 |
ROA % (ttm) | 12.61 |
ROE % (ttm) | 21.05 |
ROIC % (ttm) | 18.67 |
Dividend Yield % | 1.53 |
Altman Z-Score | 4.58 |
SHSE:603439 Number of Guru Trades
SHSE:603439 Volume of Guru Trades
Gurus Latest Trades with SHSE:603439
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603439 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guizhou Sanli Pharmaceutical Co Ltd Insider Transactions
No Available Data